CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...